Skip to main content
SpringerLink
Log in

Ovarian Epithelial Neoplasia

  • Chapter
  • First Online:
Practical Gynecologic Pathology

Part of the book series: Practical Anatomic Pathology ((PAP))

  • 905 Accesses

Abstract

Benign ovarian cysts and surface epithelial neoplasms are among the most common conditions affecting the ovary. Diagnostic criteria distinguishing cysts from benign surface epithelial neoplasia are discussed. Additionally, this chapter addresses some malignant conditions of the ovary that have overlapping features with benign processes. Each surface epithelial tumor subtype has benign, borderline, and malignant entities described. In a question and answer format, this chapter outlines diagnostic criteria distinguishing these conditions within a histotype. Finally, some surface epithelial neoplasia can mimic other histotypes including conditions not primary to the ovary. Questions outlined in this chapter address ways to approach accurate histotyping and classification.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Abbreviations

HNF:

Hepatocyte nuclear factor

LH:

Luteinizing hormone

PCOS:

Polycystic ovarian syndrome

SF1:

Steroid factor 1

UCGs:

Unilocular cystic granulosa cell tumor

References

  1. Kurman RJ. Origin and molecular pathogenesis of ovarian high-grade serous carcinoma. Ann Oncol. 2013;24(Suppl 10):x16–21.

    Article  PubMed  Google Scholar 

  2. Seidman JD, Mehrotra A. Benign ovarian serous tumors: a re-evaluation and proposed reclassification of serous “cystadenomas” and “cystadenofibromas”. Gynecol Oncol. 2005;96(2):395–401.

    Article  PubMed  Google Scholar 

  3. Qublan H, Amarin Z, Nawasreh M, Diab F, Malkawi S, Al-Ahmad N, et al. Luteinized unruptured follicle syndrome: incidence and recurrence rate in infertile women with unexplained infertility undergoing intrauterine insemination. Hum Reprod. 2006;21(8):2110–3.

    Article  CAS  PubMed  Google Scholar 

  4. Lomme M, Kostadinov S, Zhang C. Large solitary luteinized follicle cyst of pregnancy and puerperium: report of two cases. Diagn Pathol. 2011;6:3.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Mulvany NJ, Riley CB. Granulosa cell tumors of unilocular cystic type. Pathology. 1997;29(4):348–53.

    Article  CAS  PubMed  Google Scholar 

  6. Thomas EJ, Campbell IG. Molecular genetic defects in endometriosis. Gynecol Obstet Investig. 2000;50(Suppl 1):44–50.

    Article  CAS  Google Scholar 

  7. Wei J-J, William J, Bulun S. Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects. Int J Gynecol Pathol. 2011;30(6):553–68.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Bulun SE, Yilmaz BD, Sison C, Miyazaki K, Bernardi L, Liu S, et al. Endometriosis. Endocr Rev. 2019;40(4):1048–79.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Somigliana E, Vigano P, Parazzini F, Stoppelli S, Giambattista E, Vercellini P. Association between endometriosis and cancer: a comprehensive review and a critical analysis of clinical and epidemiological evidence. Gynecol Oncol. 2006;101(2):331–41.

    Article  PubMed  Google Scholar 

  10. Van Gorp T, Amant F, Neven P, Vergote I, Moerman P. Endometriosis and the development of malignant tumours of the pelvis. A review of literature. Best Pract Res Clin Obstet Gynaecol. 2004;18(2):349–71.

    Article  PubMed  Google Scholar 

  11. Takahashi K, Kurioka H, Irikoma M, Ozaki T, Kanasaki H, Miyazaki K. Benign or malignant ovarian neoplasms and ovarian endometriomas. J Am Assoc Gynecol Laparosc. 2001;8(2):278–84.

    Article  CAS  PubMed  Google Scholar 

  12. Allison KH, Swisher EM, Kerkering KM, Garcia RL. Defining an appropriate threshold for the diagnosis of serous borderline tumor of the ovary: when is a full staging procedure unnecessary? Int J Gynecol Pathol. 2008;27(1):10–7.

    Article  PubMed  Google Scholar 

  13. Ramalingam PD, Malpica A. Serous tumor of low malignant potential of the ovary0is the 10% cut off reliable? Mod Pathol. 2012;25:294A.

    Google Scholar 

  14. Hinson SA, Silva EG, Pinto K. Ovarian serous cystadenofibromas associated with a low-grade serous carcinoma of the peritoneum. Ann Diagn Pathol. 2013;17(3):302–4.

    Article  PubMed  Google Scholar 

  15. Hauptmann S, Friedrich K, Redline R, Avril S. Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria. Virchows Arch. 2017;470(2):125–42.

    Article  CAS  PubMed  Google Scholar 

  16. Folkins A, Longacre T. Low-grade serous neoplasia of the female genital tract. Surg Pathol Clin. 2019;12(2):481–513.

    Article  PubMed  Google Scholar 

  17. Seidman JD, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. Am J Surg Pathol. 1996;20(11):1331–45.

    Article  CAS  PubMed  Google Scholar 

  18. Eichorn JH, Bell DA, Young RH, Scully RE. Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns. Am J Surg Pathol. 1999;23(4):397–409.

    Article  Google Scholar 

  19. Deavers MT, Gershenson DM, Tortolero-Luna G, Malpica A, Lu KH, Silva EG. Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential: a study of 99 advanced stage cases. Am J Surg Pathol. 2002;26(9):1129–41.

    Article  PubMed  Google Scholar 

  20. Longacre TA, McKenney JK, Tazelaar HD, Kempson RL, Hendrickson MR. Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or = 5-year) follow-up. Am J Surg Pathol. 2005;29(6):707–23.

    Article  PubMed  Google Scholar 

  21. Seidman JD, Savage J, Krishnan J, Vang R, Kurman RJ. Intratumoral heterogeneity accounts for apparent progression of noninvasive serous tumors to invasive low-grade serous carcinoma: a study of 30 low-grade serous tumors of the ovary in 18 patients with peritoneal carcinomatosis. Int J Gynecol Pathol. 2020;39(1):43–54.

    Article  PubMed  Google Scholar 

  22. Bell DA, Scully RE. Ovarian serous borderline tumors with stromal microinvasion: a report of 21 cases. Hum Pathol. 1990;21(4):397–403.

    Article  CAS  PubMed  Google Scholar 

  23. McKenney JK, Balzer BL, Longacre TA. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion. Am J Surg Pathol. 2006;30(10):1209–21.

    Article  PubMed  Google Scholar 

  24. Rollins SE, Young RH, Bell DA. Autoimplants in serous borderline tumors of the ovary: a clinicopathologic study of 30 cases of a process to be distinguished from serous adenocarcinoma. Am J Surg Pathol. 2006;30(4):457–62.

    Article  PubMed  Google Scholar 

  25. Djordjevic B, Malpica A. Lymph node involvement in ovarian serous tumors of low malignant potential: a clinicopathologic study of thirty-six cases. Am J Surg Pathol. 2010;34(1):1–9.

    Article  PubMed  Google Scholar 

  26. Qian X, Hua X, Wu J, Shen Y, Cheng X, Wan X. Clinical predictors of recurrence and prognostic value of lymph node involvement in the serous borderline ovarian tumor. Int J Gynecol Cancer. 2018;28(2):279–84.

    Article  PubMed  Google Scholar 

  27. Bell DA, Weinstock MA, Scully RE. Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis. Cancer. 1988;62(10):2212–22.

    Article  CAS  PubMed  Google Scholar 

  28. Bell KA, Smith Sehdev AE, Kurman RJ. Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas. Am J Surg Pathol. 2001;25(4):419–32.

    Article  CAS  PubMed  Google Scholar 

  29. Silva EG, Gershenson DM, Malpica A, Deavers M. The recurrence and overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent. Am J Surg Pathol. 2006;30(11):1367–71.

    Article  PubMed  Google Scholar 

  30. McKenney JK, Gilks B, Kalloger S, Longacre TA. Classification of extraovarian implants in patients with ovarian serous borderline tumors (tumors of low malignant potential) based on clinical outcome. Am J Surg Pathol. 2016;40(9):1155–64.

    Article  PubMed  Google Scholar 

  31. Okoye E, Euscher ED, Malpica A. Ovarian low-grade serous carcinoma: a clinicopathologic study of 33 cases with primary surgery performed at a single institution. Am J Surg Pathol. 2016;40(5):627–35.

    Article  PubMed  Google Scholar 

  32. Malpica A, Deavers MT, Lu K, Bodurka DC, Atkinson EN, Gershenson DM, et al. Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol. 2004;28(4):496–504.

    Article  PubMed  Google Scholar 

  33. Malpica A, Deavers MT, Tornos C, Kurman RJ, Soslow R, Seidman JD, et al. Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma. Am J Surg Pathol. 2007;31(8):1168–74.

    Article  PubMed  Google Scholar 

  34. Soslow RA, Han G, Park KJ, Garg K, Olvera N, Spriggs DR, et al. Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma. Mod Pathol. 2012;25(4):625–36.

    Article  CAS  PubMed  Google Scholar 

  35. Howitt BE, Hanamornroongruang S, Lin DI, Conner JE, Schulte S, Horowitz N, et al. Evidence for a dualistic model of high-grade serous carcinoma: BRCA mutation status, histology, and tubal intraepithelial carcinoma. Am J Surg Pathol. 2015;39(3):287–93.

    Article  PubMed  Google Scholar 

  36. Bodurka DC, Deavers MT, Tian C, Sun CC, Malpica A, Coleman RL, et al. Reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group Study. Cancer. 2012;118(12):3087–94.

    Article  PubMed  Google Scholar 

  37. Ramalingam P. Morphologic, immunophenotypic, and molecular features of epithelial ovarian cancer. Oncology (Williston Park). 2016;30(2):166–76.

    Google Scholar 

  38. Kurman RJ, Shih IM. The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded. Am J Pathol. 2016;186(4):733–47.

    Article  PubMed  PubMed Central  Google Scholar 

  39. O’Neill CJ, McBride HA, Connolly LE, Deavers MT, Malpica A, McCluggage WG. High-grade ovarian serous carcinoma exhibits significantly higher p16 expression than low-grade serous carcinoma and serous borderline tumour. Histopathology. 2007;50(6):773–9.

    Article  PubMed  Google Scholar 

  40. Boyd C, McCluggage WG. Low-grade ovarian serous neoplasms (low-grade serous carcinoma and serous borderline tumor) associated with high-grade serous carcinoma or undifferentiated carcinoma: report of a series of cases of an unusual phenomenon. Am J Surg Pathol. 2012;36(3):368–75.

    Article  PubMed  Google Scholar 

  41. Mills AM, Shanes ED. Mucinous ovarian tumors. Surg Pathol Clin. 2019;12(2):565–85.

    Article  PubMed  Google Scholar 

  42. Ronnett BM, Kajdacsy-Balla A, Gilks CB, Merino MJ, Silva E, Werness BA, et al. Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior. Hum Pathol. 2004;35(8):949–60.

    Article  PubMed  Google Scholar 

  43. Seidman JD, Soslow RA, Vang R, Berman JJ, Stoler MH, Sherman ME, et al. Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images. Hum Pathol. 2004;35(8):918–33.

    Article  PubMed  Google Scholar 

  44. Hart WR. Mucinous tumors of the ovary: a review. Int J Gynecol Pathol. 2005;24(1):4–25.

    PubMed  Google Scholar 

  45. Riopel MA, Ronnett BM, Kurman RJ. Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive and metastatic carcinomas. Am J Surg Pathol. 1999;23(6):617–35.

    Article  CAS  PubMed  Google Scholar 

  46. Lee KR, Scully RE. Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas including an evaluation of 11 cases with pseudomyxoma peritonei. Am J Surg Pathol. 2000;24(11):1447–64.

    Article  CAS  PubMed  Google Scholar 

  47. Rodriguez IM, Prat J. Mucinous tumors of the ovary: a clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas. Am J Surg Pathol. 2002;26(2):139–52.

    Article  PubMed  Google Scholar 

  48. Ludwick C, Gilks CB, Miller D, Yaziji H, Clement PB. Aggressive behavior of stage I ovarian mucinous tumors lacking extensive infiltrative invasion: a report of four cases and review of the literature. Int J Gynecol Pathol. 2005;24(3):205–17.

    Article  PubMed  Google Scholar 

  49. Gouy S, Saidani M, Maulard A, Bach-Hamba S, Bentivegna E, Leary A, et al. Characteristics and prognosis of stage I ovarian mucinous tumors according to expansile or infiltrative type. Int J Gynecol Cancer. 2018;28(3):493–9.

    Article  PubMed  Google Scholar 

  50. Nomura K, Aizawa S. Noninvasive, microinvasive, and invasive mucinous carcinomas of the ovary: a clinicopathologic analysis of 40 cases. Cancer. 2000;89(7):1541–6.

    Article  CAS  PubMed  Google Scholar 

  51. Khunamornpong S, Settakorn J, Sukpan K, Suprasert P, Siriaunkgul S. Mucinous tumor of low malignant potential (“borderline” or “atypical proliferative” tumor) of the ovary: a study of 171 cases with the assessment of intraepithelial carcinoma and microinvasion. Int J Gynecol Pathol. 2011;30(3):218–30.

    Article  PubMed  Google Scholar 

  52. Bagué S, Rodriguez IM, Prat J. Sarcoma-like mural nodules in mucinous cystic tumors of the ovary revisited. Am J Surg Pathol. 2002;26(11):1467–76.

    Article  PubMed  Google Scholar 

  53. Provenza C, Young RH, Prat J. Anaplastic carcinoma in mucinous ovarian tumors. A clinicopathologic study of 34 cases emphasizing the crucial impact of stage on prognosis, their histologic spectrum, and overlap with sarcoma like mural nodules. Am J Surg Pathol. 2008;32(3):383–9.

    Article  PubMed  Google Scholar 

  54. McFarland M, Dina R, Fisher C, McCluggage WG. Osteosarcoma as malignant mural nodule in ovarian mucinous neoplasms of intestinal type: report of 2 cases. Int J Gynecol Pathol. 2015;34(4):369–73.

    Article  PubMed  Google Scholar 

  55. Desouki MM, Khabele D, Crispens MA, Fadare O. Ovarian mucinous tumor with malignant mural nodules: dedifferentiation or collision? Int J Gynecol Pathol. 2015;34(1):19–24.

    Article  PubMed  Google Scholar 

  56. Ardakani NM, Giardina T, Amanuel B, Stewart CJ. Molecular profiling reveals a clonal relationship between ovarian mucinous tumors and corresponding mural carcinomatous nodules. Am J Surg Pathol. 2017;41(9):1261–6.

    Article  Google Scholar 

  57. Shao Y, Liu Q, Haiyan S, Lu B. Ovarian mucinous tumors with mural nodules: immunohistochemical and molecular analysis of 3 cases. Diagn Pathol. 2020;15(1):35.

    Article  PubMed  PubMed Central  Google Scholar 

  58. McCluggage WG. Immunohistochemistry in the distinction between primary and metastatic ovarian mucinous neoplasms. J Clin Pathol. 2012;65(7):596–600.

    Article  PubMed  Google Scholar 

  59. Yemelyanova AV, Vang R, Judson K, Wu LS, Ronnett BM. Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification. Am J Surg Pathol. 2008;32(1):128–38.

    Article  PubMed  Google Scholar 

  60. Hu J, Khalifa RD, Roma AA, Fadare O. The pathologic distinction of primary and metastatic mucinous tumors involving the ovary: a re-evaluation of algorithms based on gross features. Ann Diagn Pathol. 2018;37:1–6.

    Article  PubMed  Google Scholar 

  61. Park CK, Kim HS. Clinicopathological characteristics of ovarian metastasis from colorectal and pancreatobiliary carcinomas mimicking primary ovarian mucinous tumor. Anticancer Res. 2018;38(9):5465–73.

    Article  PubMed  Google Scholar 

  62. Moh M, Krings G, Ates D, Aysal A, Kim GE, Rabban JT. SATB2 expression distinguishes ovarian metastases of colorectal and appendiceal origin from primary ovarian tumors of mucinous or endometrioid type. Am J Surg Pathol. 2016;40(3):419–32.

    Article  PubMed  Google Scholar 

  63. Aldaoud N, Erashdi M, Al-Khatib S, Abdo N, Al-Mohtaseb A, Graboski-Bauer A. The utility of PAX8 and SATB2 immunohistochemical stains in distinguishing ovarian mucinous neoplasms from colonic and appendiceal mucinous neoplasm. BMC Res Notes. 2019;12(1):770.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Alghamdi S, Alghaashamy K, Pinto A. Expression of SMAD4 is retained in most gynecologic tumors with mucinous differentiation. Int J Gynecol Pathol. 2019;39:493–7.

    Article  Google Scholar 

  65. Meriden Z, Yemelyanova AV, Vang R, Ronnett BM. Ovarian metastases of pancreaticobiliary tract adenocarcinomas: analysis of 35 cases, with emphasis on the ability of metastases to simulate primary ovarian mucinous tumors. American J Surg Pathol. 2011;35:276–88.

    Article  Google Scholar 

  66. Shappell HW, Riopel MA, Smith-Sehdev AE, Ronnett BM, Kurman RJ. Diagnostic criteria and behavior of ovarian seroumucinous (endocervical-type mucinous and mixed cell-type) tumors. Am J Surg Pathol. 2002;26(12):1529–41.

    Article  PubMed  Google Scholar 

  67. Vang R, Gown AM, Barry TS, Wheeler DT, Ronnett BM. Ovarian atypical proliferative (borderline) mucinous tumors: gastrointestinal and seromucinous (endocervical-like) types are immunophenotypically distinctive. Int J Gynecol Pathol. 2006;25(1):83–9.

    Article  PubMed  Google Scholar 

  68. Taylor J, McCluggage WG. Ovarian seromucinous carcinoma. Report of a series of a newly categorized and uncommon neoplasm. Am J Surg Pathol. 2015;39(7):983–92.

    Article  PubMed  Google Scholar 

  69. Rutgers JKL. Mullerian mucinous/mixed epithelial (seromucinous) ovarian tumors. AJSP Rev Rep. 2016;21(5):206–13.

    Google Scholar 

  70. Rambau PF, McIntyre JB, Taylor J, Lee S, Ogilvie T, Sienko A, et al. Morphologic reproducibility, genotyping, and immunohistochemical profiling do not support a category of seromucinous carcinoma of the ovary. Am J Surg Pathol. 2017;41(5):685–95.

    Article  PubMed  Google Scholar 

  71. Fadare O, Parkash V. Pathology of endometrial and clear cell carcinoma of the ovary. Surg Pathol Clin. 2019;12(2):529–64.

    Article  PubMed  Google Scholar 

  72. Bell KA, Kurman RJ. A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary. Am J Surg Pathol. 2000;24(11):1465–79.

    Article  CAS  PubMed  Google Scholar 

  73. Chen S, Leitao MM, Tornos C, Soslow RA. Invasion patterns in stage I endometrioid and mucinous ovarian carcinomas: a clinicopathologic analysis emphasizing favorable outcomes in carcinomas without destructive stromal invasion and the occasional malignant course of carcinomas with limited destructive stromal invasion. Mod Pathol. 2005;18(7):903–11.

    Article  PubMed  Google Scholar 

  74. Mansor S, McCluggage WG. Endometrioid adenocarcinoma of the ovary mimicking serous borderline tumor: report of a series of cases. Int J Gynecol Pathol. 2014;33(5):470–6.

    Article  PubMed  Google Scholar 

  75. Woodbeck R, Kelemen LE, Kobel M. Ovarian endometrioid carcinoma misdiagnosed as mucinous carcinoma: an underrecognized problem. Int J Gynecol Pathol. 2019;38(6):568–75.

    Article  CAS  PubMed  Google Scholar 

  76. Kobel M, Bak J, Bertelsen BI, Carpen O, Grove A, Hansen ES, et al. Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistry. Histopathology. 2014;64(7):1004–13.

    Article  PubMed  Google Scholar 

  77. Kobel M, Luo L, Grevers X, Lee S, Brooks-Wilson A, Gilks B, et al. Ovarian carcinoma histotype: strengths and limitations of integrating morphology with immunohistochemical predictions. Int J Gynecol Pathol. 2019;38(4):353–62.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Young RH, Prat J, Scully RE. Ovarian endometrioid carcinomas resembling sex cord-stromal tumors. A clinicopathological analysis of 13 cases. Am J Surg Pathol. 1982;6(6):513–22.

    Article  CAS  PubMed  Google Scholar 

  79. Ordi J, Schammel DP, Rasekh L, Tavassoli FA. Sertoliform endometrioid carcinomas of the ovary: a clinicopathologic and immunohistochemical study of 113 cases. Mod Pathol. 1999;12(10):933–40.

    CAS  PubMed  Google Scholar 

  80. Fujibayashi M, Aiba M, Iizuka E, Igarashi A, Okamura M, Takagi K. Granulosa cell tumor-like variant of endometrioid carcinoma of the ovary exhibiting nuclear clearing with biotin activity. A subtype showing close macroscopic, cytologic, and histologic similarity to adult granulosa cell tumor. Arch Pathol Lab Med. 2003;129(10):1288–94.

    Article  Google Scholar 

  81. Katoh T, Yasuda M, Hasegawa K, Kozawa E, Maniwa J, Sasano H. Estrogen-producing endometrioid adenocarcinoma resembling sex cord-stromal tumor of the ovary: a review of four postmenopausal cases. Diagn Pathol. 2012;7:164.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Lewis MR, Deavers MT, Silva EG, Malpica A. Ovarian involvement by metastatic colorectal adenocarcinoma. Still a diagnostic challenge. Am J Surg Pathol. 2006;30(2):177–84.

    Article  PubMed  Google Scholar 

  83. Lewis MR, Euscher ED, Deavers MT, Silva EG, Malpica A. Metastatic colorectal adenocarcinoma involving the ovary with elevated serum CA125: a potential diagnostic pitfall. Gynecol Oncol. 2007;105(2):395–8.

    Article  CAS  PubMed  Google Scholar 

  84. Soliman PT, Slomovitz BM, Broaddus RR, Sun CC, Oh JC, Eifel PJ, et al. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases. Gynecol Oncol. 2004;94(2):456–62.

    Article  PubMed  Google Scholar 

  85. McCluggage WG. Pathologic staging of endometrial carcinomas: selected areas of difficulty. Adv Anat Pathol. 2018;25(2):71–84.

    Article  PubMed  Google Scholar 

  86. Casey L, Singh N. Metastases to the ovary arising from endometrial, cervical and fallopian tube cancer: recent advances. Histopathology. 2020;76(1):37–51.

    Article  PubMed  Google Scholar 

  87. Fukunaga M, Normura K, Ishikawa E, Ushigome S. Ovarian atypical endometriosis: its close association with malignant epithelial tumours. Histopathology. 1997;30(3):249–55.

    Article  CAS  PubMed  Google Scholar 

  88. Orezzoli JP, Russell AH, Oliva E, Del Carmen MG, Eichhorn J, Fuller AF. Prognostic implication of endometriosis in clear cell carcinoma of the ovary. Gynecol Oncol. 2008;110(3):336–44.

    Article  CAS  PubMed  Google Scholar 

  89. Noli S, Cipriani S, Scarfone G, Villa A, Grossi E, Monti E, et al. Long term survival of ovarian endometriosis associated clear cell and endometrioid ovarian cancers. Int J Gynecol Cancer. 2013;23(2):244–8.

    Article  PubMed  Google Scholar 

  90. Scarfone G, Bergamini A, Noli S, Villa A, Cipriani S, Taccagni G, et al. Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study. Gynecol Oncol. 2014;133(3):480–4.

    Article  PubMed  Google Scholar 

  91. Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, et al. Significance of ovarian endometriosis on the prognosis of ovarian clear cell carcinoma. Int J Gynecol Cancer. 2018;28(1):11–8.

    Article  PubMed  Google Scholar 

  92. Matias-Guiu X, Stewart CJ. Endometriosis-associated ovarian neoplasia. Pathology. 2018;50(2):190–204.

    Article  PubMed  Google Scholar 

  93. DeLair D, Oliva E, Kobel M, Macias A, Gilks CB, Soslow RA. Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases. Am J Surg Pathol. 2011;35(1):36–44.

    Article  PubMed  Google Scholar 

  94. Kobel M, Kalloger SE, Carrick J, Huntsman D, Asad H, Oliva E, et al. A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary. Am J Surg Pathol. 2009;33(1):14–21.

    Article  PubMed  Google Scholar 

  95. Li Q, Cheng X, Jie J, Zhang J, Huang W. The application value of HNF-1β transcription factor in the diagnosis of ovarian clear cell carcinoma. Int J Gynecol Pathol. 2016;35(1):66–71.

    Article  PubMed  Google Scholar 

  96. Rekhi B, Deodhar KK, Menon S, Maheshwari A, Bajpai J, Ghosh J, et al. Napsin A and WT1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma. APMIS. 2018;126(1):45–55.

    Google Scholar 

  97. Kandalaft PL, Gown AM, Isacson C. The lung-restricted marker Napsin A is highly expressed in clear cell carcinomas of the ovary. Am J Clin Pathol. 2014;142(6):830–6.

    Google Scholar 

  98. Fadare O, Zhao CQ, Khabele D, Parkash V, Quick CM, Gwin K, et al. Comparative analysis of Napsin A, alpha-methylacyl-coenzyme a racemase (AMACR, p504s) and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumours. Pathology. 2015;47(2):105–11.

    Article  CAS  PubMed  Google Scholar 

  99. Silva EG, Young RH. Endometrioid neoplasms with clear cells: a report of 21 cases in which the alteration is not typical secretory type. Am J Surg Pathol. 2007;31(8):1203–8.

    Article  PubMed  Google Scholar 

  100. Nogales FF, Prat J, Schuldt M, Cruz-Viruel N, Kaur B, D’Angelo E, et al. Germ cell tumour growth patterns originating from clear cell carcinomas of the ovary and endometrium: a comparative immunohistochemical study favouring their origin from somatic stem cells. Histopathology. 2018;72(4):634–47.

    Article  PubMed  Google Scholar 

  101. Austin RM, Norris HJ. Malignant Brenner tumor and transitional cell carcinoma of the ovary: a comparison. Int J Gynecol Pathol. 1987;6(1):29–39.

    Article  CAS  PubMed  Google Scholar 

  102. Cuatrecasas M, Catasus L, Palacios J, Prat J. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas. Am J Surg Pathol. 2009;33(4):556–67.

    Article  PubMed  Google Scholar 

  103. Miles PA, Norris HJ. Proliferative and malignant Brenner tumors of the ovary. Cancer. 1972;30(1):174–86.

    Article  CAS  PubMed  Google Scholar 

  104. Arey LB. The origin and form of the Brenner tumor. Am J Obstet Gynecol. 1961;81:743–51.

    Article  CAS  PubMed  Google Scholar 

  105. Silverberg SG. Brenner tumor of the ovary. A clinicopathologic study of 60 tumors in 54 women. Cancer. 1971;28(3):588–96.

    Article  CAS  PubMed  Google Scholar 

  106. Logani S, Oliva E, Amin MB, Folpe AL, Cohen C, Young RH. Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications. Am J Surg Pathol. 2003;27(11):1434–41.

    Article  PubMed  Google Scholar 

  107. Kurman RJCM, Herrington CS, et al. WHO classification of tumours of female reproductive organs. Lyon: International Agency for Research on Cancer; 2014.

    Google Scholar 

  108. Fox H, Agrawal K, Langley FA. The Brenner tumour of the ovary. A clinicopathological study of 54 cases. J Obstet Gynaecol Br Commonw. 1972;79(7):661–5.

    Article  CAS  PubMed  Google Scholar 

  109. Lamping JD, Blythe JG. Bilateral Brenner tumors: a case report and review of the literature. Hum Pathol. 1977;8(5):583–5.

    Article  CAS  PubMed  Google Scholar 

  110. Roma AA, Masand RP. Different staining patterns of ovarian Brenner tumor and the associated mucinous tumor. Ann Diagn Pathol. 2015;19(1):29–32.

    Article  PubMed  Google Scholar 

  111. Kuhn E, Ayhan A, Shih Ie M, Seidman JD, Kurman RJ. Ovarian Brenner tumour: a morphologic and immunohistochemical analysis suggesting an origin from fallopian tube epithelium. Eur J Cancer. 2013;49(18):3839–49.

    Article  PubMed  Google Scholar 

  112. Roma AA, Masand RP. Ovarian Brenner tumors and Walthard nests: a histologic and immunohistochemical study. Hum Pathol. 2014;45(12):2417–22.

    Article  CAS  PubMed  Google Scholar 

  113. Kuhn E, Ayhan A, Shih Ie M, Seidman JD, Kurman RJ. The pathogenesis of atypical proliferative Brenner tumor: an immunohistochemical and molecular genetic analysis. Mod Pathol. 2014;27(2):231–7.

    Article  CAS  PubMed  Google Scholar 

  114. Uzan C, Dufeu-Lefebvre M, Fauvet R, Gouy S, Duvillard P, Darai E, et al. Management and prognosis of borderline ovarian Brenner tumors. Int J Gynecol Cancer. 2012;22(8):1332–6.

    Article  PubMed  Google Scholar 

  115. Seidman JD, Khedmati F. Exploring the histogenesis of ovarian mucinous and transitional cell (Brenner) neoplasms and their relationship with Walthard cell nests: a study of 120 tumors. Arch Pathol Lab Med. 2008;132(11):1753–60.

    Article  PubMed  Google Scholar 

  116. Kato H, Kanematsu M, Furui T, Morishige K, Hirose Y. Ovarian mucinous cystadenoma coexisting with benign Brenner tumor: MR imaging findings. Abdom Imaging. 2013;38(2):412–6.

    Article  PubMed  Google Scholar 

  117. Euscher ED, Malpica A. Neuroendocrine cells as a component of ovarian Brenner tumors: the source of rare ovarian carcinoid tumors associated with these neoplasms. Mod Pathol. 2009;22(Suppl 1):212A.

    Google Scholar 

  118. Roth LM, Goheen MP, Broshears JR. Malignant Brenner tumor of the ovary with transformation to trabecular carcinoid: an imunocytochemical and electron microscopic study. Int J Gynecol Pathol. 2012;31(1):91–7.

    Article  PubMed  Google Scholar 

  119. Terada T, Tateoka K. Ovarian cystic tumor composed of Brenner tumor and struma ovarii. Int J Clin Exp Pathol. 2012;5(3):274–7.

    PubMed  PubMed Central  Google Scholar 

  120. Tafe LJ, Muller KE, Ananda G, Mitchell T, Spotlow V, Patterson SE, et al. Molecular genetic analysis of ovarian Brenner tumors and associated mucinous epithelial neoplasms: high variant concordance and identification of mutually exclusive RAS driver mutations and MYC amplification. Am J Pathol. 2016;186(3):671–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  121. Gezginc K, Karatayli R, Yazici F, Acar A, Celik C, Capar M, et al. Malignant Brenner tumor of the ovary: analysis of 13 cases. Int J Clin Oncol. 2012;17(4):324–9.

    Article  PubMed  Google Scholar 

  122. Nasioudis D, Sisti G, Holcomb K, Kanninen T, Witkin SS. Malignant Brenner tumors of the ovary; a population-based analysis. Gynecol Oncol. 2016;142(1):44–9.

    Article  PubMed  Google Scholar 

  123. Ali RH, Seidman JD, Luk M, Kalloger S, Gilks CB. Transitional cell carcinoma of the ovary is related to high-grade serous carcinoma and is distinct from malignant Brenner tumor. Int J Gynecol Pathol. 2012;31(6):499–506.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Elizabeth D. Euscher

  2. Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

    Jian-Jun Wei

Authors
  1. Elizabeth D. Euscher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jian-Jun Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elizabeth D. Euscher .

Editor information

Editors and Affiliations

  1. Department of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA

    Jian-Jun Wei

  2. Department of Pathology, Yale School of Medicine, New Haven, CT, USA

    Pei Hui

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Euscher, E.D., Wei, JJ. (2021). Ovarian Epithelial Neoplasia. In: Wei, JJ., Hui, P. (eds) Practical Gynecologic Pathology. Practical Anatomic Pathology. Springer, Cham. https://doi.org/10.1007/978-3-030-68608-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-68608-6_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-68607-9

  • Online ISBN: 978-3-030-68608-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation